A 32-year-old woman with polycystic ovary syndrome has been using a COC containing drospirenone for 4 years. She asks about the long-term risk of ovar...

Question

A 32-year-old woman with polycystic ovary syndrome has been using a COC containing drospirenone for 4 years. She asks about the long-term risk of ovarian cancer. What should she be told?

Accepted Answer

Long-term CHC use is associated with a significant reduction in ovarian cancer risk - approximately 50% reduction with 5+ years of use. The protective effect persists for decades after stopping

Answer

CHC increases ovarian cancer risk

Answer

CHC has no effect on ovarian cancer risk

Answer

The protective effect only applies to women with PCOS

Answer

Only Levonorgestrel-containing COCs are protective

uk-dfsrh MCQ (SBA): CHC Ovarian Cancer Protection Long-Term

A 32-year-old woman with polycystic ovary syndrome has been using a COC containing drospirenone for 4 years. She asks about the long-term risk of ovarian cancer. What should she be told?